Fig 1: CC16 serum concentrations are significantly increased in patients experiencing either SARS-CoV-2 or non-pulmonary sepsis infection. Serum levels of n = 16 subjects hospitalized for severe SARS-CoV-2 infection and of n = 12 subjects hospitalized for severe sepsis infection were compared to age- and sex-matched healthy control subjects using Student’s t-tests. This displays significant higher serum concentrations in severe infection with and without pulmonary focus of infection. Data are presented as individual CC16 serum levels and as boxplots indicating the median, 25th, 75th percentile, minimum and maximum values.